Headquartered within the consumer cyclical sector, Kewaunee Scientific Corporation focuses on Furnishings, Fixtures & Appliances services and products. Kewaunee Scientific Corporation, together with its subsidiaries, designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products in the United States. The $104.4M market capitalization puts KEQU squarely in micro-cap range for its industry. It operates through two segments, Lab Products Group (LPG) and International.
Market Cap
$104.4M
Beta
0.71
P/E (TTM)
10.96
P/E (Fwd)
16.85
EPS (TTM)
$3.32
EPS (Fwd)
$2.16
ROE
14.6%
ROA
5.6%
Cash
$9.9M
Total Debt
$56.8M
Free CF
$14.1M
52W Change
-37.5%
Annual Financials
Cash vs Debt
The company holds $9.9M in cash, though total debt stands at $56.8M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $14.1M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 14.6%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 5.6% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $219.5M (2023) to $282.0M (2026), reflecting a 28% increase over the period.
The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Kewaunee Scientific Corporation and its sector.